Official UK procurement notice
Procurement of Tacrolimus Suspension from Specials Laboratory
Authority: Belfast Health & Social Care Trust (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£85,000published contract · exc. VAT
Awarded 9 Jun 2022no call for competition
Awarded to Specials Laboratory
What is being bought
Published requirement descriptionProcurement of Tacrolimus Suspension from Specials Laboratory
CPV: Medical equipments, pharmaceuticals and personal care products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £85,0001 contract exc. VAT
Bids received 1
Contracts signed 1latest 9 Jun 2022
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Specials Laboratory | £85,000 † | — | Awarded |
Contracts
Procurement of Tacrolimus Suspension from Specials Laboratory · Specials Laboratory
- Signed
- 9 Jun 2022
- Value
- £85,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 15 Jun 2022, 13:12 BST
- Last source update
- 15 Jun 2022, 13:12 BST
- Authority reference
DACPM2022-19- FTS notice number
2022/S 000-016413- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0346c2Find a Tender
- Why no open competition
- Additional deliveries by the original supplier ordered under the strict conditions stated in the directive
- Published justification
These essential medicines are required for continuity of patient care medicines are only available from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Specials LaboratoryAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.